The latest research on long COVID symptoms, treatments & more with Andrea Garcia, JD, MPH


American Medical Association (AMA)

AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, discusses the latest research on long COVID, as well as #omicron variant XBB.1.5 and other #SARSCoV2 subvariants. Also covering how the Biden Administration’s decision to end COVID-19 national emergency and U.S. public health emergency on May 11 will affect hospitals, physicians and patients—while the World Health Organization (WHO) maintains the COVID-19 pandemic is still a global health emergency. American Medical Association CXO Todd Unger hosts.

Watch, read, or listen to Sandra Fryhofer, MD, AMA Board Chair’s recent #vaccine and bivalent booster episode, here:…

00:00 #AMA Update for Feb. 1, 2023 00:32 Biden Administration to end #COVID19 emergency declarations on May 11 01:53 What’s driving the White House’s decision? 03:21 What does this mean for hospitals, physicians and patients? 03:36 How much will #COVID vaccines cost? 04:14 Are COVID tests still free? 04:32 COVID treatment costs in the US 05:25 COVID cases in the U.S. 05:38 COVID-19 hospitalizations and deaths 05:53 XBB 1.5 variant 07:17 Effective COVID treatments: Paxlovid, Lagevrio, Veklury and more 08:02 Contact ASPR at with questions 08:38 New data from long COVID study 09:55 Long COVID symptoms 10:37 Women are worst affected by long COVID, study finds 11:10 #coronavirus still considered global health emergency by #WHO